Brain Tumor Clinical Trials

Find Brain Tumor Clinical Trials Near You

Cerebrospinal Fluid Leak Incidence, Management and Risk Factor After Supratentorial Craniotomy for Intracranial Tumors: a Prospective Observational Study.

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Cerebrospinal fluid is a clear fluid that surrounds and protects the brain. During surgery for brain tumors, neurosurgeons often need to open the covering of the brain (the dura) to reach the tumor. At the end of the operation, this covering is carefully closed again. In some cases, the closure might not be completely adequate leading to cerebrospinal fluid leak. This leakage may collect under the scalp or flow out through the surgical wound. When this happens, the surgical wound may not heal properly, and the risk of infection can increase. These complications can delay recovery and may postpone additional treatments, such as radiotherapy or chemotherapy, that are often needed after brain tumor surgery. Although cerebrospinal fluid leakage is less common after supratentorial craniotomy (surgery on the upper part of the brain) than after other types of brain surgery, it remains a challenging complication and has not been well studied in this group of patients. The aim of this study is to determine how often cerebrospinal fluid leakage occurs after supratentorial craniotomy for intracranial tumors, identify factors that increase the risk of leakage, and evaluate how these leaks are managed. Understanding these factors may help reduce the occurrence of cerebrospinal fluid leakage and improve postoperative recovery in the future.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male or female at least 18 years old

• Qualified for a craniotomy due to supratentorial intracranial tumor

Locations
Other Locations
Poland
Department of Neurosurgery of Medical Univeristy of Warsaw
RECRUITING
Warsaw
Contact Information
Primary
Michal Senger, M.D.
michal.senger@wum.edu.pl
+48 791 760 040
Time Frame
Start Date: 2026-02-03
Estimated Completion Date: 2028-04
Participants
Target number of participants: 200
Treatments
Patients qualified for a supratentorial craniotomy for intracranial tumor
Patients who are qualified for a supratentorial craniotomy for intracranial tumor who need neither urgent neurosurgical treatment or secondary surgery due to tumor progression.
Sponsors
Leads: Medical University of Warsaw

This content was sourced from clinicaltrials.gov